Cohen SH, Louie TJ, Sims M, Wang EEL, et al. Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial. JAMA 2022;328:2062-2064.
PMID: 36260754